Monday, July 01, 2024
Cannabis Bioscience International Holdings has announced the submission of their first pair of patents, focusing on innovative treatment methodologies for breast and pancreatic cancers. These patents are currently undergoing legal review for registration.
The scientific team at CBIH has dedicated extensive research efforts to develop novel approaches tailored to addressing the challenges posed by breast and pancreatic cancers, which affect millions worldwide.
Breast cancer, impacting approximately one in eight women in the United States over their lifetime, and pancreatic cancer, known for its late-stage diagnosis and low survival rates, are particularly severe.
PhD in Science with a specialization in Microbiology, emphasizes the urgency of their approach: "Given the stark statistics associated with these cancers, our team recognizes the critical need for aggressive yet targeted interventions.
Goal is to not only target tumors but also protect surrounding tissues, harnessing the inherent anti-tumor properties of cannabinoids."
Looking ahead, CBIH plans to continue their innovation momentum by submitting an additional 3 to 4 patents monthly throughout the year.
Key areas of focus include treatments for herpes zoster, knee osteoarthritis, and Alzheimer's disease, utilizing cannabinoids' antiviral, anti-inflammatory, and neuroprotective benefits.
To support these efforts, CBIH is expanding their research team, particularly in patent and formulation development.
They recently welcomed Sheila Tarqui, whose extensive background in biology, pharmaceutical chemistry, public health, and dermatic cosmetics from leading universities makes her a valuable addition to their team.
Additionally, CBIH is actively recruiting medical specialists in oncology and cardiology to enhance their exploration of cannabinoids' therapeutic applications.
With cardiovascular diseases remaining a leading global cause of death, their aim is to explore the potential of cannabinoids in this field and develop innovative treatments.
The importance of protecting their intellectual property: "These strategies are crucial in securing and safeguarding our groundbreaking medical advancements, which integrate cutting-edge therapies, artificial intelligence, and advanced biotechnological techniques."
CBIH remains committed to leveraging cannabinoids' potential to enhance patient outcomes and contribute to global health initiatives, redefining medicine and treatment strategies in the process.
Source: globenewswire.com
